How To Play BHEL, L&T Finance, GVK Power? #AskBQ
.jpg?downsize=1010:568 "How To Play BHEL, L&T Finance, GVK Power? #AskBQ")
#AskBQ is BloombergQuint's daily offering where market experts help investors make the right investment choice in the equity market.
On Thurday's episode, Jay Thakkar of Anand Rathi and Avinash Gorakshakar of Joindre Capital Services gave their views on BHEL, L&T Finance, GVK Power and much more.
Watch the full conversation:
Here are the edited excerpts from the conversation:
Raj Shah: Bought 2,000 shares of Parag Milk Foods at Rs 285 with a five-year view. Should I add more or exit?
Avinash Gorakshakar: Suggest you hold with a 12-18 month view so that you get a decent risk-reward.
Sushant Jha: I want to invest in BHEL with a three-month view. Is this the right time to invest?
Jay Thakkar: I prefer L&T in the sector. I would suggest you avoid BHEL.
Deepak Toshniwal: I bought 100 shares of PI Industries at Rs 872 with a long-term view. Should I hold or sell?
Avinash Gorakshakar: I would recommend you to hold with a price target of Rs 1,050-1,100.
Abhishek Gupta: Is Dewan Housing Finance a good long-term bet? If so, What will be the one-year target?
Avinash Gorakshakar: I would suggest you to buy the stock with 12-18 month view.
Prathamesh Kothari: I want to buy Kajaria Ceramic with a six-month view. Is this the right time to invest?
Jay Thakkar: I would suggest you to avoid the counter in the current market scenario.
Santosh Kumar: I want to invest in JSW Steel with a two-year view. Please suggest.
Avinash Gorakshakar: One can buy at current levels.
Jipin Balakrishnan: I bought 1,000 shares of Firstsource at Rs 45. What is the target/exit price? Can I hold with a one-year view?
Avinash Gorakshakar: The stock is the good bet in the sector. one can expect 15-20 percent upside.
Nishanth Sharma: I bought 2,000 shares of GVK Power & Infra at Rs. 17.7. Should I hold or exit?
Jay Thakkar: One can hold with a stop-loss at Rs 13. One can also buy at current levels.
Andiappan: I bought 100 shares of L&T Finance at Rs 176 with a long-term view. Should I average at current levels?
Avinash Gorakshakar: You can average the stock. You can hold an 18-24 month view.
Harsh: I bought 100 shares of India Glycol at Rs 400 with a one-year view. Please suggest.
Jay Thakkar: I would suggest you to book profit and exit the stock.
Mridul Gupta: Is the right the right time to invest in HDFC with a long-term view?
Avinash Gorakshakar: You can buy the stock and hold with a three-year view.
Sumeet Shivhare: I want to invest in Sun Pharma with a two-year view. Is this the right time to invest?
Jay Thakkar: I would suggest you to buy with a view of year or more. It is expected to deliver around 35-40 percent.
Shivang Bhatt: I want to invest in Max Financial Services with a long-term view. Please suggest.
Jay Thakkar: I prefer companies like HDFC Life.
Analyst disclosures: both the analysts do not hold any stocks that were discussed today.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint's digital and social media platforms provide views of only SEBI registered investment advisors/analysts.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Prashant Jain's 3P Investment Managers Bought 2.5% Stake In This Healthcare Firm
After slowing acquisitions, Entero now has the opportunity to extract greater value from the network. The key, however, will be execution.
-
Taxing A Promise: The Unsettled Story Of GST On Corporate Guarantees
These concerns are particularly relevant for businesses in the infrastructure, real estate, power and EPC sectors, where guarantees run for several years over the duration of the project and involve substantial amounts.
-
Who Will Care When Women Work? That Is The Wrong Question
The debate on women and work becomes strangely patronising when even our most enlightened elites assume that care is a woman's natural duty.
-
AI Disruption Is Exponential, Businesses Need A Margin Of Safety: HDFC AMC's Navneet Munot
According to Munot, one of the biggest challenges in assessing AI's impact is that the pace of change is exponential rather than linear.
-
The AI Race Is Bigger Than AI Models | The Week In Whys
The AI race and the humanoid race may look like two different technology stories. But underneath, they are increasingly about the same thing: who controls the ecosystem needed to build the technology.
-
FCNR Deposits Beat Estimates, RBI To Pull Out Rs 6-7 Lakh Crore: Pranjul Bhandari
HSBC's chief India economist says the central bank must drain up to Rs 7 lakh crore of surplus liquidity within a fortnight, either through a cash reserve ratio hike or dollar sales, as Foreign Currency Non-Resident (Bank) deposits far outpace expectations
-
Joining The Dots | CAS Turmoil, The Large-Cap Debate And Zee's Almost Rs 22,000-Crore Haircut
Time bends on Dalal Street, Dylan's lyrics haunt the large-cap debate, and Zee's promoter picks up the bargain of the year.
